Crypto markets are still consolidating; the charts are shaping up constructively, but I want to see further strength to drag us out of these sideways ranges.

For now, I'm remaining patient and scanning for relative strength. That way, when momentum does return, I have a good list of coins that have the potential to be the next leaders.

Here's one coin that meets this criteria.

No setup gets me more excited than buying a fresh new all-time high.

There are no bagholders looking to unload their losing position to breakeven. Every investor or trader holding a long position is making money. And every trader holding a short position is losing money and the only way they correct that sad state of affairs is to buy stock to stop their losses.

In other words, blue skies above.

This doesn't guarantee success on a long trade here, of course. But these are the types of trades that commonly lead to my biggest gains.

Here's a weekly chart of semiconductor name Analog Devices $ADI:

In today’s Daily Digest, we’ll review:

1. New position in XLB.
2. No adjustments are needed today.
3. No exits since the last report.
4. Current status of open campaigns.

Let’s dig in!

From the Desk of Steve Strazza and Alfonso Depablos

The largest insider buy on today's list comes via two Form 4 filings by Sensata Technologies Holding plc $ST director John Mirshekari.

Mirshekari reported a purchase of ST shares with a total value of $10.6 million.

The Small-cap Indexes in America have had a tough time for a while now.

Since the start of 2022, both of these Small-cap Indexes have actually produced a negative return.

The S&P600 Small-cap Index requires companies to have a track record of earnings in order to be included in the index.

The Russell2000 lets anyone in. It doesn't matter how much money you lose, if your market cap is above $300 Million, then you're in.

Both of them have been terrible.

From the Desk of Ian Culley @IanCulley

Stock market bulls are scooping and scoring as the Nasdaq Composite, the S&P 500, and the Dow Jones Industrial Average all show green. 

Stocks and rocks should benefit on the heels of renewed rate-cut hopes. 

Today, I’ll outline a name that checks both boxes. 

Spoiler alert: It’s a prime candidate for a short squeeze…

From the Desk of Steve Strazza @Sstrazza

Welcome to The Minor Leaguers.

We've had some great trades come out of this small-cap-focused column since we launched it back in 2020 and started rotating it with our flagship bottom-up scan, Under the Hood.

For the first year or so, we focused only on Russell 2000 stocks with a market cap between $1 and $2B.

That was fun, but we wanted to branch out a bit and allow some new stocks to find their way onto our list.

We expanded our universe to include some mid-caps.

To make the cut for our Minor Leaguers list now, a company must have a market cap between $1 and $4B.

And it doesn't have to be a Russell component — it can be any US-listed equity. With participation expanding around the globe, we want all those ADRs in our universe.

The same price and liquidity filters are applied. Then, as always, we sort by proximity to new highs in order to...

From the Desk of Ian Culley @IanCulley

Stock market bulls are scooping and scoring as the Nasdaq, S&P 500, and Dow indexes all see green. 

Stocks and rocks should benefit on the heels of renewed rate-cut hopes. 

Today, I’ll outline a name that checks both boxes. 

Spoiler alert: It’s a prime candidate for a short squeeze…

Check out the precious metal trading company, A-Mark Precious Metals $AMRK:

A-Mark popped up on our freshly squeezed scan, carrying a 23.6% short interest with ten days to cover.

While AMRK proved an easy short last fall, remaining short-sellers may have outstayed their welcome. AMRK has gained more than 70% since late February. Buyers are now driving prices to the upper bounds of a multi-year range, just shy of a new all-time high.

Buying base breakouts and riding new all-times are two of our favorite trading pastimes. Plus, vulnerable bears provide an added perk as they will likely fuel an explosive rally.

If and when...

Today's trade is in a name that currently sports a 15% short interest which equates to approximately 7 days to cover. This could be significant fuel for a blast off if the current post-earnings momentum propels this stock above 52-week highs.

The countdown to launch is ticking, so lets get involved.

In today’s Daily Digest, we’ll review:

1. No new positions today.
2. Adjustment to XHB position.
3. No exits since the last report.
4. Current status of open campaigns.

Let’s dig in!

From the Desk of Steve Strazza and Alfonso Depablos

The largest insider buy on today's list comes via two Form 4 filings by Eli Samaha, founder and managing partner of Madison Avenue Partners LP.

Samaha and Madison Avenue reported a purchase of $13 million in Theravance Biopharma $TBPH.

It's amazing what price action can do to change sentiment.

We went from frothy optimism just a couple of months ago, to a much more pessimistic environment for investors.

This table below is a great summary of the different gauges we look at to measure sentiment and what they've done over the past month.

The blue diamonds are the current readings and the gray triangles represent where these were a month ago.